Keyvan Shabafrouz

Affiliations

Département d'Oncologie, CHUV, Lausanne, Switzerland.

Publications (2)

Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study.

Annals of oncology : official journal of the European Society for Medical Oncology

Avec: P-F Petit , D Daoudlarian , S Latifyan , H Bouchaab , N Mederos , J Doms , K Abdelhamid , N Ferahta , L Mencarelli , V Joo , R Bartolini , A Stravodimou , K Shabafrouz , G Pantaleo , S Peters , M Obeid

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.

Nature reviews. Clinical oncology

Avec: Filipe Martins , Latifyan Sofiya , Gerasimos P Sykiotis , Faiza Lamine , Michel Maillard , Montserrat Fraga , Keyvan Shabafrouz , Camillo Ribi , Anne Cairoli , Yan Guex-Crosier , Thierry Kuntzer , Olivier Michielin , Solange Peters , Georges Coukos , Francois Spertini , John A Thompson , Michel Obeid

Réseau de co-auteurs

P-F Petit 1 collaboration

D Daoudlarian 1 collaboration

S Latifyan 1 collaboration

H Bouchaab 1 collaboration

N Mederos 1 collaboration

J Doms 1 collaboration

K Abdelhamid 1 collaboration

N Ferahta 1 collaboration

L Mencarelli 1 collaboration

V Joo 1 collaboration

R Bartolini 1 collaboration

A Stravodimou 1 collaboration

K Shabafrouz 1 collaboration

G Pantaleo 1 collaboration

S Peters 1 collaboration

M Obeid 1 collaboration

Filipe Martins 1 collaboration

Latifyan Sofiya 1 collaboration

Gerasimos P Sykiotis 1 collaboration

Faiza Lamine 1 collaboration

Michel Maillard 1 collaboration

Montserrat Fraga 1 collaboration

Camillo Ribi 1 collaboration

Anne Cairoli 1 collaboration

Yan Guex-Crosier 1 collaboration

Thierry Kuntzer 1 collaboration

Olivier Michielin 1 collaboration

Solange Peters 1 collaboration

Georges Coukos 1 collaboration

Francois Spertini 1 collaboration

John A Thompson 1 collaboration

Michel Obeid 1 collaboration